Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series

CONCLUSION: Treatment of pediatric uveitis with tofacitinib can be a valuable second-line treatment option and useful alternative in low- and middle-income countries.PMID:38441607 | DOI:10.1080/09273948.2024.2323671
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Authors: Source Type: research